CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Casi Pharmaceuticals, Inc.  (CASI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Casi Pharmaceuticals's Leverage Ratio

CASI's quarterly Leverage Ratio and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:                        

CASI Leverage Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Equity Change 69.85 % 314.96 % - - -
Y / Y Total Liabilities Change -20.54 % -29.79 % -41.84 % -26.2 % -25.64 %
Leverage Ratio MRQ 0.42 0.36 0.33 0.55 0.89
Overall Ranking # 689 # 749 # 749 # 0 #
Seq. Equity Change -11.51 % -7.43 % 29.71 % 59.85 % 116.19 %
Seq. Total Liabilities Change 2.38 % 0.19 % -20.67 % -2.35 % -9.55 %



Leverage Ratio second quarter 2017 Comment
Due to net new borrowings of 2.38%, Leverage Ratio detoriated to 0.42, below company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the second quarter 2017, 57 other companies have achieved lower Leverage Ratio than Casi Pharmaceuticals. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are CASI Customers?
Leverage Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 58
Healthcare Sector # 217
Overall Market # 689


Leverage Ratio Statistics
High Average Low
13.82 2.32 0.06
(Sep 30 2014)   (Jun 30 2014)


You need to upgrade your Flash Player


Financial Statements
Casi Pharmaceuticals's Equity $ 17 Millions Visit CASI's Balance sheet
Casi Pharmaceuticals's Total Liabilities $ 7 Millions Visit CASI's Balance sheet
Source of CASI's Sales Visit CASI's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingJun 30 2017, within Biotechnology & Drugs Industry Leverage RatioJun 30 2017 MRQ Total LiabilitiesJun 30 2017 MRQ Equity
Intelgenx Technologies Corp.  1.04 $ 5.398  Millions$ 5.166  Millions
Genocea Biosciences, Inc.  1.03 $ 19.821  Millions$ 19.207  Millions
Eiger Biopharmaceuticals, Inc.  1.01 $ 20.788  Millions$ 20.672  Millions
Cerecor Inc.  0.93 $ 2.912  Millions$ 3.135  Millions
Jounce Therapeutics, inc.  0.90 $ 158.745  Millions$ 175.508  Millions
Azurrx Biopharma, Inc.  0.89 $ 4.120  Millions$ 4.645  Millions
Biogen Inc.  0.88 $ 10,173.800  Millions$ 11,573.600  Millions
Soligenix, Inc.  0.87 $ 3.152  Millions$ 3.622  Millions
Citius Pharmaceuticals, Inc.  0.86 $ 9.973  Millions$ 11.594  Millions
Alliance Bioenergy Plus, Inc.  0.86 $ 4.286  Millions$ 5.013  Millions
Acorda Therapeutics Inc  0.82 $ 563.166  Millions$ 689.720  Millions
Dimension Therapeutics, Inc.  0.78 $ 28.138  Millions$ 36.073  Millions
Aerie Pharmaceuticals Inc  0.77 $ 141.942  Millions$ 185.042  Millions
Aptevo Therapeutics Inc.  0.65 $ 33.325  Millions$ 51.420  Millions
Repligen Corp  0.62 $ 117.820  Millions$ 190.943  Millions
Emergent Biosolutions Inc.  0.56 $ 348.174  Millions$ 620.599  Millions
Crispr Therapeutics Ag  0.54 $ 107.172  Millions$ 197.803  Millions
Atyr Pharma Inc  0.54 $ 21.441  Millions$ 40.031  Millions
Ampliphi Biosciences Corp  0.53 $ 5.245  Millions$ 9.861  Millions
Tracon Pharmaceuticals, Inc.  0.52 $ 9.059  Millions$ 17.295  Millions
Voyager Therapeutics, Inc.  0.50 $ 53.123  Millions$ 105.291  Millions
Axovant Sciences Ltd.  0.50 $ 102.806  Millions$ 206.197  Millions
Pulmatrix, Inc.  0.49 $ 7.731  Millions$ 15.789  Millions
Pdl Biopharma, Inc.  0.48 $ 394.173  Millions$ 818.798  Millions
Uluru Inc.  0.45 $ 3.153  Millions$ 7.039  Millions
Neuralstem, Inc.  0.43 $ 3.340  Millions$ 7.693  Millions
Xenetic Biosciences, Inc.  0.42 $ 4.862  Millions$ 11.509  Millions
Casi Pharmaceuticals, Inc.  0.42 $ 7.107  Millions$ 17.026  Millions
Intellia Therapeutics, Inc.  0.41 $ 77.390  Millions$ 187.585  Millions
Myokardia Inc  0.37 $ 45.568  Millions$ 124.195  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
BUKX's Profile
Stock Price
BUKX's Financials
BUKX's Expectations
Business Description
Fundamentals
Charts & Quotes
BUKX's News
Suppliers
BUKX's Competitors
Customers & Markets
Economic Indicators
BUKX's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com